THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 94 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $201,000 | -98.7% | 27,095 | -97.5% | 0.00% | -98.9% |
| Q2 2021 | $15,898,000 | +10.5% | 1,094,936 | +55.4% | 0.09% | +12.8% |
| Q1 2021 | $14,381,000 | +26.2% | 704,608 | +9.9% | 0.08% | -11.4% |
| Q4 2020 | $11,395,000 | +3856.6% | 641,235 | +3191.6% | 0.09% | +2833.3% |
| Q3 2020 | $288,000 | -94.4% | 19,481 | -92.0% | 0.00% | -94.8% |
| Q2 2020 | $5,131,000 | -26.0% | 244,471 | -18.5% | 0.06% | -22.7% |
| Q1 2020 | $6,933,000 | +245.4% | 300,000 | +287.0% | 0.08% | +400.0% |
| Q4 2019 | $2,007,000 | +44.8% | 77,528 | +26.9% | 0.02% | +36.4% |
| Q2 2018 | $1,386,000 | -79.7% | 61,110 | -78.3% | 0.01% | -80.0% |
| Q1 2018 | $6,816,000 | +297.7% | 281,055 | +277.9% | 0.06% | +48.6% |
| Q3 2014 | $1,714,000 | -56.9% | 74,370 | -40.4% | 0.04% | -56.0% |
| Q2 2014 | $3,981,000 | – | 124,872 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |